Main > A1. CORP. INDEX. G-Gm > Gilead Sciences/P C2
This data is not available for free
Gilead Sciences/P C2's subsections
1998. 12.18.1998. (Isis Pharma.)
1999. 03.01.1999. (Merger)
2001. 01.07.2001. (Antibiotics)
2001. 05.21.2001. (Focus)
2001. 08.27.2001. (Corp. Sale)
2001. 12.03.2001. (Business Sale)
2001. 12.03.2001. (Focus)
2002. 06.06.2002. (Hepatology)
2002. 08.08.2002. (Hepatology)
2002. 08.19.2002. (Hepatology)
2002. 12.09.2002. (Focus)
2002. 12.09.2002. (Parent of)
2002. 12.09.2002. (Revenues)
2003. 03.17.2003. (AIDS)
2003. 03.17.2003. (Hepatology)
2003. 03.17.2003. (Revenues)
2003. 03.31.2003. (AIDS)
2003. 09.12.2003. (Licensor)
2005. 04.04.2005. (AIDS)
2005. 04.04.2005. (Executive)
2007. 04.09.2007. VP Chem Dev.
2008. 01.10.2008. (AIDS Targets) >
2008. 03.19.2008. Hepato.>HBV
2008. 05.29.2008. (Cardio.>PAH)
2008. 06.13.2008. (Pneumo.>CF)
2008. 09.22.2008. CSO
2010. 06.25.2010. (Corp. Acq.)
2011. 03.30.2011. Yale Uni.>Onco.
2011. 08.08.2011. Genentech
2012. 01.17. Acq. Pharmasset Inc.
2012. 01.19.2012. Sr. VP Onco.
2012. 04.19.2012. Hepato.>HCV
2012. 06.06.2012. Health Policy
2012. 07.16.2012. AIDS Prevn
2012. 08.02.2012. IN Partners AIDS
2012. 12.12.2012. Corp. Acq.
2013. 01.24.2013. AIDS TAF
2013. 02.19.2013. Teva Pharma.
2013. 03.10.2013. CV.>Angina>Diab.
2013. 05.28. AIDS 4 Combi. T diso
2013. 11.18. Onco.>CLL
2013. 12.13. AIDS 3 Combi.
2014. 01.13. Onco.>iNHL
2014. 04.21. AIDS>Cobicistat
2014. 04.21. AIDS>Elvitegravir
2014. 05.07. $5 B Share RePurchase
2014. 05.20. Pneumo.>RSV
2014. 09.15. Hepato.>HCV>IN
2014. 11.18. Hepato.>HCV>S+L
2014. 12.19. Onco.>B Cell Malig.
2015. 01.06. Hepato.>NASH
2015. 01.26. Hepato.>HCV>IN
2015. 03.26. Hepato.>HCV>S
2015. 10.29. Wuxi Pharmatech
2015. 11.23. AIDS 4 Combi. T alaf
2015. 12.17. RA .. Galapagos
2016. 03.16. Bahamas MFG; HIV
2016. 04.04. AIDS D
2016. 04.04. NASH & Liver Dis.
2016. 06.23. AIDS O
2016. 08.22. AIDS T
2016. 08.31. Hepato.>Patent Dispute
2017. 07.18. Hepato.>HCV>S+V+V
2017. 08.28. Acq. Kite Pharma
2017. 09.14. Senior Unsecured Notes
2017. 10.18. Onco.>Lymphoma
2017. 12.07. Acq. Cell Design Labs
2018. 04.30. Verily
2018. 09.12. Precision BioSciences
2018. 09.24. Hepato.>HCV>Generics
2018. 10.31. Tango Therapeutics
2018. 12.04. Hepato.>HCV>S+L CN OK
2018. 12.19. Scholar Rock
2018. 12.20. Onco.>Agenus
2019. 03.26. AIDS B+D JP>OK
2019. 04.16. NASH Insitro
2019. 05.08. Goldfinch Bio
2019. 06.19. Nurix Therapeutics
2019. 07.14. Galapagos
2019. 07.19. Novartis
2019. 07.22. Durect
2019. 08.09. AIDS B+D CN>OK
2019. 12.20. Hepato.>HCV>CN OK
2020. 03.02. Acq. Forty Seven
2020. 03.19. Hepato.>HCV>CN OK
2020. 04.07. Acq. Forty Seven
2020. 04.10. COVID-19 Treat
2020. 04.21. Kite oNKo-innate
2020. 04.29. COVID-19 Treat
2020. 05.01. COVID-19 Treat USA>EUA
2020. 05.07. COVID-19 Treat JP>OK
2020. 07.03. COVID-19 Treat EU>OK
2020. 08.11. HIV>PrEP>CN>OK
2020. 08.17. Onco.>Tango Therapeuti
2020. 09.13. Onco.>Acq Immunomedics
2020. 09.25. Rheuma.>RA>EU>OK
2020. 10.22. COVID-19 Treat USA>OK
2020. 10.23. Onco.>Acq Immunomedics
2020. 12.10. ACQ. MYR GmbH.
2021. 02.01. HIV Vacc. Gritstone
2021. 03.15. HIV Merck
2021. 10.18. Pediatric HIV
2022. 05.02. Dragonfly
2022. 08.04. Acq. MiroBio
2022. 08.22. AIDS>EU>OK (*)
2022. 09.20. Acq. MiroBio
2022. 11.02. HBV>USA>OK (*)
2022. 11.29. HIV>EU>OK
2022. 12.22. AIDS>USA>OK (*)
2023. 02.03. Onco.>Breast C.>USA>OK
2023. 05.09. Onco.>Acq. XinThera
2023. 06.23. HDV Infection
2023. 09.07. $2B Sr UnSecured Notes
2024. 02.12. Acq. CymaBay Therapeu
2024. 03.22. Acq. CymaBay Therapeu
Patents
Web-Site
Z - OK
Gilead Sciences/P C2's products
This section has no products